These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS. Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683 [Abstract] [Full Text] [Related]
23. Reopening of the ductus arteriosus after closure with indomethacin: importance of sustained effective indomethacin serum concentrations. Gal P, Ransom JL, Shaffer CL, Smith MS, Carlos RQ, Brown Y, Schall S. J Pediatr; 1996 May; 128(5 Pt 1):719. PubMed ID: 8627452 [No Abstract] [Full Text] [Related]
28. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus. Weir FJ, Smith A, Littleton P, Carter N, Hamilton PA. Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905 [Abstract] [Full Text] [Related]
36. Effect of fetal lung maturation on the treatment of patent ductus arteriosus in premature infants. Bai C, Chang Q, Wu H, Meng F. Minerva Pediatr (Torino); 2023 Feb 25; 75(1):148-150. PubMed ID: 36149095 [No Abstract] [Full Text] [Related]
38. [Research progress on auxiliary indexes and methods of diagnosis and treatment of patent ductus arteriosus in preterm]. Wang LY, Wang BJ, Gao XY. Zhonghua Er Ke Za Zhi; 2024 Mar 25; 62(4):381-384. PubMed ID: 38527513 [Abstract] [Full Text] [Related]